Ifp Advisors, Inc Lumos Pharma, Inc. Transaction History

Ifp Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$7.36 - $11.36 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$9.75 - $13.44 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$11.58 - $31.11 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$13.61 - $35.91 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$13.25 - $16.5 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	SELL	$7.76 - $16.99 $2,809 - $6,150	-362 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$0.89 - $8.85 $322 - $3,203	362 New	362 $4,000

2.2M

Ticker LUMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,396,070
Market Cap $36.4M
Description
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.